Abnormally Low and High Ankle-Brachial Indices Are Independently Associated with Increased Left Ventricular Mass Index in Chronic Kidney Disease

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Su, Ho Ming ^a,b,c   Lin, Tsung Hsien ^a,c   Hsu, Po Chao ^a   Chu, Chun Yuan ^a   Lee, Wen Hsien ^a   Chen, Szu Chia ^a,b   Lee, Chee Siong ^a,c   Voon, Wen Chol ^a,c   Lai, Wen Ter ^a,c   Sheu, Sheng Hsiung ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CODING; RISK ASSESSMENT; STAGING; TAIWAN;

AGED; ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TAIWAN; TREATMENT OUTCOME;

EID: 84866034526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044732     Document Type: Article

References (37)

1. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, et al. (1991) Edinburgh artery study: Prevalence of asymptomatic and symptomatic peripheral zarterial disease in the general population. Int J Epidemiol 20: 384-392.
2. Hasimu B, Li J, Nakayama T, Yu J, Yang J, et al. (2006) Ankle brachial index as a marker of atherosclerosis in chinese patients with high cardiovascular risk. Hypertens Res 29: 23-28.
3. Orchard TJ, Strandness DE Jr, (1993) Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the american heart association and the american diabetes association 18-20 september 1992, new orleans, louisiana. Diabetes Care 16: 1199-1209.
4. de Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, et al. (2005) Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factors. Kidney Int Suppl 67:S44-47.
5. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H, (2002) The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: Requirements for diagnostics. Am J Kidney Dis 40: 472-479.
6. O'Hare A, Johansen K, (2001) Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 12: 2838-2847.
7. O'Hare AM, Hsu CY, Bacchetti P, Johansen KL, (2002) Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 13: 497-503.
8. Webb AT, Franks PJ, Reaveley DA, Greenhalgh RM, Brown EA, (1993) Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg 7: 523-527.
9. Guerrero A, Montes R, Munoz-Terol J, Gil-Peralta A, Toro J, et al. (2006) Peripheral arterial disease in patients with stages iv and v chronic renal failure. Nephrol Dial Transplant 21: 3525-3531.
10. Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, et al. (2003) Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 14: 1591-1598.
11. Chen SC, Chang JM, Hwang SJ, Tsai JC, Liu WC, et al. (2010) Ankle brachial index as a predictor for mortality in patients with chronic kidney disease and undergoing haemodialysis. Nephrology (Carlton) 15: 294-299.
12. Albuquerque PF, Albuquerque PH, Albuquerque GO, Servantes DM, Carvalho SM, et al. (2012) Ankle-brachial index and ventricular hypertrophy in arterial hypertension. Arq Bras Cardiol 98: 84-86.
13. Ix JH, Katz R, Peralta CA, de Boer IH, Allison MA, et al. (2010) A high ankle brachial index is associated with greater left ventricular mass mesa (multi-ethnic study of atherosclerosis). J Am Coll Cardiol 55: 342-349.
14. Aboyans V, Ho E, Denenberg JO, Ho LA, Natarajan L, et al. (2008) The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 48: 1197-1203.
15. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, et al. (1997) Calcification of medial elastic fibers and aortic elasticity. Hypertension 29: 999-1006.
16. Chen JH, Chen SC, Liu WC, Su HM, Chen CY, et al. (2009) Determinants of peripheral arterial stiffness in patients with chronic kidney disease in southern taiwan. Kaohsiung J Med Sci 25: 366-373.
17. Chen SC, Chang JM, Liu WC, Huang JC, Tsai JC, et al. (2012) Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Nephrol Dial Transplant 27: 1064-1070.
18. Chen SC, Chang JM, Liu WC, Wang CS, Su HM, et al. (2012) Arterial stiffness in patients with chronic kidney disease. Am J Med Sci 343: 109-113.
19. O'Hare AM, Glidden DV, Fox CS, Hsu CY, (2004) High prevalence of peripheral arterial disease in persons with renal insufficiency: Results from the national health and nutrition examination survey 1999-2000. Circulation 109: 320-323.
20. Levey AS, Coresh J, Bolton K, Culleton B, Harvey KS, et al. (2002) Initiative KDOQ. K/doqi clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57: 450-458.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463.
23. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, et al. (2003) Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement--a survey of 12517 subjects. Atherosclerosis 166: 303-309.
24. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, et al. (2002) Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25: 359-364.
25. Yokoyama H, Shoji T, Kimoto E, Shinohara K, Tanaka S, et al. (2003) Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb 10: 253-258.
26. Vickery S, Stevens PE, Dalton RN, van Lente F, Lamb EJ, (2006) Does the id-ms traceable mdrd equation work and is it suitable for use with compensated jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 21: 2439-2445.
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130: 461-470.
28. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB, (2006) Mortality and cardiovascular risk across the ankle-arm index spectrum: Results from the cardiovascular health study. Circulation 113: 388-393.
29. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, et al. (2004) Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The strong heart study. Circulation 109: 733-739.
30. Levin A, Singer J, Thompson CR, Ross H, Lewis M, (1996) Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354.
31. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, et al. (1999) Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34: 125-134.
32. Devereux RB, Reichek N, (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618.
33. Fu W, Ye C, Mei C, Rong S, Wang W, (2006) Reverse correlation between ankle-brachial index and left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrology (Carlton) 11: 9-14.
34. Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, et al. (2000) Impact of arterial stiffening on left ventricular structure. Hypertension 36: 489-494.
35. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB, (1995) Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 25: 83-90.
36. Chen SC, Chang JM, Liu WC, Chen YY, Chen LI, et al. (2012) The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease. Hypertens Res [Epub ahead of print].
37. Nardi E, Palermo A, Mule G (2012) Inappropriately high left ventricular mass: Marker of very high cardiovascular risk in patients with chronic kidney disease? Hypertens Res [Epub ahead of print].